bpc-157 ulcerative colitis phase ii clinical trial Stable gastric pentadecapeptide BPC 157 in the treatment of and ischemia and reperfusion in rats: New insights BPC-157 as an Investigational Peptide
Description
Working concentration scales with reconstitution volume and vial size
It is very effective, particularly for men with erectile dysfunction
It presents as a painful rash, often accompanied by blisters, that usually appears on one side of the body or face
Regular water can promote bacterial growth which can degrade the peptide leading to loss of potency and contamination
Research shows that CU may have underlying causes, and studies have found links between autoimmune GI disorders and CU, further suggesting the gut-skin axis might play a role in its pathogenesis
